Calcium, magnesium, and phosphate abnormalities in the emergency department

Emergency Medicine Clinics of North America

Volumn 32, Issue 2, 2014, Pages 349-366

  Chang, Wan Tsu W ^a   Radin, Bethany ^a   McCurdy, Michael T ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

Hypercalcemia; Hypermagnesemia; Hyperphosphatemia; Hypocalcemia; Hypomagnesemia; Hypophosphatemia

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE; CALCIUM; CALCIUM CHLORIDE; GLUCONATE CALCIUM; LOOP DIURETIC AGENT; MAGNESIUM; PHOSPHATE; POTASSIUM DIHYDROGEN PHOSPHATE; POTASSIUM SPARING DIURETIC AGENT; SODIUM CHLORIDE; SODIUM DIHYDROGEN PHOSPHATE; VITAMIN D;

CALCIUM BLOOD LEVEL; CALCIUM HOMEOSTASIS; CALCIUM METABOLISM; CELL METABOLISM; CLINICAL FEATURE; CRITICALLY ILL PATIENT; DIET RESTRICTION; DISEASE SEVERITY; EMERGENCY WARD; HEART CONDUCTION; HUMAN; HYPERCALCEMIA; HYPERMAGNESEMIA; HYPERPHOSPHATEMIA; HYPOCALCEMIA; HYPOMAGNESEMIA; HYPOPHOSPHATEMIA; MAGNESIUM BLOOD LEVEL; MAGNESIUM METABOLISM; MORBIDITY; NEUROMUSCULAR FUNCTION; PATHOPHYSIOLOGY; PHOSPHATE BLOOD LEVEL; PHOSPHATE METABOLISM; PREVALENCE; PRIORITY JOURNAL; RENAL REPLACEMENT THERAPY; REVIEW; VITAMIN D DEFICIENCY;

HYPERCALCEMIA; HYPERMAGNESEMIA; HYPERPHOSPHATEMIA; HYPOCALCEMIA; HYPOMAGNESEMIA; HYPOPHOSPHATEMIA;

CALCIUM; CRITICAL ILLNESS; EMERGENCY SERVICE, HOSPITAL; HOMEOSTASIS; HUMANS; INCIDENCE; MAGNESIUM; METABOLIC DISEASES; PHOSPHATES;

EID: 84899067202     PISSN: None     EISSN: 07338627     Source Type: Journal    
DOI: 10.1016/j.emc.2013.12.006     Document Type: Review

References (37)

1. Tentori F., Blayney M.J., Albert J.M., et al. Mortality risk for dialysis patients with different levels of serum calcium, phosphorus, and PTH: the Dialysis Outcomes and Practice Patterns Study (DOPPS). Am J Kidney Dis 2008, 52:519-530.
2. Hästbacka J., Pettilä V. Prevalence and predictive value of ionized hypocalcemia among critically ill patients. Acta Anaesthesiol Scand 2003, 47:1264-1269.
3. Liamis G., Rodenburg E.M., Hofman A., et al. Electrolyte disorders in community subjects: prevalence and risk factors. Am J Med 2013, 126:256-263.
4. Stewart A.F. Hypercalcemia associated with cancer. NEngl J Med 2005, 352:373-379.
5. McCurdy M.T., Shanholtz C.B. Oncologic emergencies. Crit Care Med 2012, 40(7):2212-2222.
6. Zivin J.R., Gooley T., Zager R.A., et al. Hypocalcemia: a pervasive metabolic abnormality in the critically ill. Am J Kidney Dis 2001, 4:689-698.
7. Guerrera M.P., Volpe S.L., Mao J.J. Therapeutic uses of magnesium. Am Fam Physician 2009, 80:157-162.
8. Liao F., Folsom A.R., Brancati F.L. Is low magnesium concentration a risk factor for coronary heart disease? The Atherosclerosis Risk in Communities (ARIC) Study. Am Heart J 1998, 136:480-490.
9. Fawcett W.J., Haxby E.J., Male D.A. Magnesium: physiology and pharmacology. BrJ Anaesth 1999, 83:302-320.
10. Limaye C., Londhey V., Nadkart M., et al. Hypomagnesemia in critically ill medical patients. JAssoc Physicians India 2011, 59:3-8.
11. Martin K.J., González E.A., Slatopolsky E. Clinical consequences and management of hypomagnesemia. JAm Soc Nephrol 2009, 20:2291-2295.
12. Shiber J.R., Mattu A. Serum phosphate abnormalities in the emergency department. JEmerg Med 2002, 23:395-400.
13. Geerse D.A., Bindels A.J., Kuiper M.A., et al. Treatment of hypophosphatemia in the intensive care unit: a review. Crit Care 2010, 14:R147.
14. Hruska K.A., Mathew S., Lund R., et al. Hyperphosphatemia of chronic kidney disease. Kidney Int 2008, 74(2):148-157.
15. Connolly G.M., Cunningham R., McNamee P.T., et al. Elevated serum phosphate predicts mortality in renal transplant recipients. Transplantation 2009, 87:1040-1044.
16. Tonelli M., Sacks F., Pfeffer M., et al. Relation between serum phosphate level and cardiovascular event rate in people with coronary disease. Circulation 2005, 112:2627-2633.
17. Bringhurst F. Hormones and disorders of mineral metabolism. Williams textbook of endocrinology 2011, Saunders, Philadelphia. 12th edition. S. Melmed, K.S. Polonsky, P.R. Larsen (Eds.).
18. Jahnen-Dechent W., Ketteler M. Magnesium basics. Clin Kidney J 2012, 5(Suppl 1):i3-14.
19. Moe S.M. Disorders involving calcium, phosphorus, and magnesium. Prim Care 2008, 35:215-237.
20. Hofbauer L.C., Heufelder A.E. Role of receptor activator of nuclear factor-κB ligand and osteoprotegerin in bone cell biology. JMol Med 2001, 79:243-253.
21. Mayer G.P., Hurst J.G. Sigmoidal relationship between parathyroid hormone secretion rate and plasma calcium concentration in calves. Endocrinology 1978, 102:1036-1042.
22. Carpinteri R., Porcelli T., Mejia C., et al. Glucocorticoid-induced osteoporosis and parathyroid hormone. JEndocrinol Invest 2010, 33(Suppl 7):16-21.
23. Silverberg S.J., Walker M.D., Bilezikian J.P. Asymptomatic primary hyperparathyroidism. JClin Densitom 2013, 16:14-21.
24. Seymour J.F., Gagel R.F. Calcitriol: the major humoral mediator of hypercalcemia in Hodgkin's disease and non-Hodgkin's lymphomas. Blood 1993, 82:1383-1394.
25. Pitt S.C., Sippel R.S., Chen H. Secondary and tertiary hyperparathyroidism, state of the art surgical management. Surg Clin North Am 2009, 89:1227-1239.
26. National Cancer Institute. Hypercalcemia (PDQ). 2010. p. 1-25. Available at:. Accessed October 28, 2013. http://cancer.gov/cancertopics/pdq/supportivecare/hypercalcemia/HealthProfessional.
27. Pecherstorfer M., Brenner K., Zojer N. Current management strategies for hypercalcemia. Treat Endocrinol 2003, 2:273-292.
28. Fong J., Khan A. Hypocalcemia: updates in diagnosis and management for primary care. Can Fam Physician 2012, 58:158-162.
29. Steele T., Kolamunnage-Dona R., Downey C., et al. Assessment and clinical course of hypocalcemia in critical illness. Crit Care 2013, 17:R106.
30. Hurley K., Baggs D. Hypocalcemic cardiac failure in the emergency department. JEmerg Med 2005, 28:155-159.
31. Lee J.W. Fluid and electrolyte disturbances in critically ill patients. Electrolyte Blood Press 2010, 8:72-81.
32. Rude R.K. Magnesium depletion and hypermagnesemia. Primer on the metabolic bone diseases and disorders of mineral metabolism 2009, 325-328. JohnWiley & Sons, Inc, Hoboken (NJ). C.J. Rosen, J.E. Compston, J.B. Lian (Eds.).
33. Ravn H.B. Pharmacological effects of magnesium on arterial thrombosis-mechanisms of action?. Magnes Res 1999, 12:191-199.
34. Dai L.-J., Raymond L., Friedman P.A., et al. Mechanisms of amiloride stimulation of Mg2+ uptake in immortalized mouse distal convoluted tubule cells. Am J Physiol 1997, 272(2 Pt 2):F249-F256.
35. Janigan D., Hirsch D., Klassen G., et al. Calcified subcutaneous arterioles with infarcts of the subcutis and skin ("calciphylaxis") in chronic renal failure. Am J Kidney Dis 2000, 35:588-597.
36. Delmez J., Slatopolsky E. Hyperphosphatemia - its consequences and treatment in patients with chronic renal disease. Am J Kidney Dis 1992, 19:303-317.
37. Hamada J., Tamai K., Ono W., et al. Uremic tumoral calcinosis in hemodialysis patients: clinicopathological findings and identification of calcific deposits. JRheumatol 2006, 33:119-126.